Matthew Maxwell Donley - 02 Mar 2023 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
EVP, Ops & Strategy
Signature
/s/ Matthew Maxwell Donley
Issuer symbol
AUPH
Transactions as of
02 Mar 2023
Net transactions value
$0
Form type
4
Filing time
06 Mar 2023, 15:29:36 UTC
Previous filing
23 Nov 2022
Next filing
22 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Award +271,134 +205% 403,141 02 Mar 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of Restricted Stock Units (RSUs) payable solely in common stock of the Issuer that vest in three (3) equal annual installments on the first, second and third anniversary of the grant date.
F2 Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F3 The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes the 271,134 newly awarded RSUs, 104,080 RSUs previously reported in Table II, which vests in three (3) equal annual installments beginning March 2, 2022 (Prior RSUs), and 27,927 shares of common stock. On March 2, 2023, 34,693 of Prior RSUs vested and 69,387 of Prior RSUs remained unvested.